This study investigates high dose-rate brachytherapy for treating unresectable liver malignancies. This study examines both primary and secondary types.
The study evaluates the clinical effectiveness of this treatment method. It focuses on safety and how well it works for local tumor control, comparing results to past data.
- Who can participate: Participants must be over 18 with up to five unresectable liver tumors, at least 3 cm, and near large blood vessels or sensitive structures.
- Study details: Participants will receive high dose-rate brachytherapy.